Health

Results: 5269-5280 of 5640

eMed Healthcare UK promises continuity and expansion following successful acquisition of Babylon - marking a new era for digital-first primary care in the UK

PR Newswire associated0

Endeavor BioMedicines Enters License Agreement with Hummingbird Bioscience for Worldwide Rights to HMBD-501, a Next Generation HER3-Targeted Antibody-Drug Conjugate (ADC)

PR Newswire associated0

Waters Accelerates Oligonucleotide Bioanalysis with the Launch of OligoWorks™ SPE Workflow and Kits

PR Newswire associated0

Qilu Pharmaceutical to Showcase Novel Anti-Cancer Drug QL1706 at ESMO Congress 2023

(Photo: Business Wire)

4Moving Biotech Completes the Recruitment of Its Phase I Clinical Trial in Patients With Knee Osteoarthritis

TASO launches new online resource for universities to support student mental health

Virology Education Presents the Demystifying Long COVID-19 International Conference 2023 7-9 December 2023

PR Newswire associated0

Daewoong Pharmaceutical to Participates in CPHI Worldwide 2023, Showcasing Own Novel Drug in the Global Market

Protembis Announces FDA Approval of its Pivotal Investigational Device Exemption (IDE) Study

PR Newswire associated0

ProstACT SELECT Study of TLX591 Interim Readout: Positive Results Confirm Safety and Tolerability

European Commission Approves ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage III Hodgkin Lymphoma in Combination with AVD

PR Newswire associated0

Alkermes to Report Third Quarter Financial Results on October 25, 2023